University of Lille Nord de France-ko ikertzaileekin lankidetzan egindako argitalpenak (7)

2024

  1. LANDMARK comparison of early outcomes of newer-generation Myval transcatheter heart valve series with contemporary valves (Sapien and Evolut) in real-world individuals with severe symptomatic native aortic stenosis: a randomised non-inferiority trial

    The Lancet, Vol. 403, Núm. 10445, pp. 2695-2708

  2. TransCatheter aortic valve implantation and fractional flow reserve-guided percutaneous coronary intervention versus conventional surgical aortic valve replacement and coronary bypass grafting for treatment of patients with aortic valve stenosis and multivessel or advanced coronary disease: The transcatheter valve and vessels trial (TCW trial): Design and rationale

    American Heart Journal, Vol. 270, pp. 86-94

2023

  1. Fractional flow reserve or 3D-quantitative-coronary-angiography based vessel-FFR guided revascularization. Rationale and study design of the prospective randomized fast III trial

    American Heart Journal, Vol. 260, pp. 1-8

2022

  1. Transapical mitral valve implantation for treatment of symptomatic mitral valve disease: a real-world multicentre experience

    European Journal of Heart Failure, Vol. 24, Núm. 5, pp. 899-907

2020

  1. Intestinal Lipid Metabolism Genes Regulated by miRNAs

    Frontiers in Genetics, Vol. 11

  2. Intravenous alteplase for stroke with unknown time of onset guided by advanced imaging: systematic review and meta-analysis of individual patient data

    The Lancet, Vol. 396, Núm. 10262, pp. 1574-1584

2017

  1. Transcatheter Aortic Valve Replacement in Pure Native Aortic Valve Regurgitation

    Journal of the American College of Cardiology, Vol. 70, Núm. 22, pp. 2752-2763